BioCentury | Aug 29, 2020
Finance

Aug. 28 Quick Takes: Synthego raises $100M D round, plus Clene, Aetion, Antengene, Athira, Compass

...Fight Against COVID-19”).Antengene files for HK IPOOne month after raising its $97 million series C, Antengene Corp....
...developing COMP360, a high-purity polymorphic crystalline formulation of psilocybin, for treatment-resistant depression. BC Staff Synthego Corp. Clene Nanomedicine Inc. Antengene Corp. Athira...
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...the German government (see “GSK-CureVac Deal” ). Fidelity leads Antengene C round Shanghai cancer company Antengene Corp....
BioCentury | Jun 10, 2020
Management Tracks

iTeos builds out team with CFO, R&D VP; plus Constellation, SwanBio, Akcea, Amplyx, Antengene and more

...C in May, bringing the total funds raised in the round to over $90 million. Antengene Corp....
...plc (NASDAQ:ALKS). Robin Sawka, BioCentury Staff Constellation Pharmaceuticals Inc. Inspire Medical Systems Inc. Akcea Therapeutics Inc. iTeos Therapeutics S.A. Amplyx Pharmaceuticals Inc. Antengene Corp. DalCor...
BioCentury | Apr 14, 2020
Management Tracks

Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more

...CEO of Achillion Pharmaceuticals Inc., which Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) acquired in January. Cancer company Antengene Corp....
...Ladonchamps, ObsEva’s VP of corporate affairs and finance, will become interim CFO. Robin Sawka, BioCentury Staff CytoDyn Inc. Antengene Corp. Bolt...
BioCentury | Jan 8, 2020
Company News

Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

...Dova Pharmaceuticals Inc. until its acquisition by Swedish Orphan Biovitrum AB (SSE:SOBI). China-focused cancer company Antengene Corp....
...search and evaluation at BMS. Elizabeth S. Eaton, Staff Writer Fred Hutchinson Cancer Research Center GlaxoSmithKline plc Provention Bio Inc. Antengene Corp. Revitope...
BioCentury | Jan 7, 2020
Company News

Management tracks: New director for CMS’s CMMI, plus FibroGen, Turning Point, Akcea, Antengene, Biocon and more

...President Sarah Boyce and COO Jeff Goldberg (see “Unexpected Shakeup at Akcea” ). Cancer company Antengene Corp....
BioCentury | Dec 20, 2019
Product Development

Pharma spinouts: a snapshot of where and how pharmas spin out their assets

...pharma spinouts, five companies were spun out in China. In 2017, Celgene Corp. spun out Antengene Corp....
BioCentury | Nov 7, 2019
Product Development

AZ replants R&D roots in China, goes all-in on innovation

...Medical Technology licensed AZD3229, a c-Kit inhibitor; Antengene Corp....
...Lilly and Co. Novoheart Holdings Inc. Sun Pharmaceutical Industries Ltd. Antengene Corp. Abbisko...
BioCentury | Jan 4, 2019
Financial News

China's Antengene raises $120M series B round

...Corporate Venture Fund, Taikang and existing investors Qiming Venture Partners and TF Capital. Qiming led Antengene’s...
...liposarcoma and Phase II testing for diffuse large B cell lymphoma and glioblastoma in China. Antengene...
...Korea and other East and Southeast Asian territories, excluding Japan (see "Celgene, Antengene Deal" ). Antengene...
BioCentury | Jan 2, 2019
Financial News

China's Antengene raises $120M series B round

...Corporate Venture Fund, Taikang and existing investors Qiming Venture Partners and TF Capital. Qiming led Antengene’s...
...liposarcoma and Phase II testing for diffuse large B cell lymphoma and glioblastoma in China. Antengene...
...Southeast Asian territories, excluding Japan (see "China's Antengene in Deal for Celgene Cancer Candidate" ). Antengene...
Items per page:
1 - 10 of 19
BioCentury | Aug 29, 2020
Finance

Aug. 28 Quick Takes: Synthego raises $100M D round, plus Clene, Aetion, Antengene, Athira, Compass

...Fight Against COVID-19”).Antengene files for HK IPOOne month after raising its $97 million series C, Antengene Corp....
...developing COMP360, a high-purity polymorphic crystalline formulation of psilocybin, for treatment-resistant depression. BC Staff Synthego Corp. Clene Nanomedicine Inc. Antengene Corp. Athira...
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...the German government (see “GSK-CureVac Deal” ). Fidelity leads Antengene C round Shanghai cancer company Antengene Corp....
BioCentury | Jun 10, 2020
Management Tracks

iTeos builds out team with CFO, R&D VP; plus Constellation, SwanBio, Akcea, Amplyx, Antengene and more

...C in May, bringing the total funds raised in the round to over $90 million. Antengene Corp....
...plc (NASDAQ:ALKS). Robin Sawka, BioCentury Staff Constellation Pharmaceuticals Inc. Inspire Medical Systems Inc. Akcea Therapeutics Inc. iTeos Therapeutics S.A. Amplyx Pharmaceuticals Inc. Antengene Corp. DalCor...
BioCentury | Apr 14, 2020
Management Tracks

Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more

...CEO of Achillion Pharmaceuticals Inc., which Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) acquired in January. Cancer company Antengene Corp....
...Ladonchamps, ObsEva’s VP of corporate affairs and finance, will become interim CFO. Robin Sawka, BioCentury Staff CytoDyn Inc. Antengene Corp. Bolt...
BioCentury | Jan 8, 2020
Company News

Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

...Dova Pharmaceuticals Inc. until its acquisition by Swedish Orphan Biovitrum AB (SSE:SOBI). China-focused cancer company Antengene Corp....
...search and evaluation at BMS. Elizabeth S. Eaton, Staff Writer Fred Hutchinson Cancer Research Center GlaxoSmithKline plc Provention Bio Inc. Antengene Corp. Revitope...
BioCentury | Jan 7, 2020
Company News

Management tracks: New director for CMS’s CMMI, plus FibroGen, Turning Point, Akcea, Antengene, Biocon and more

...President Sarah Boyce and COO Jeff Goldberg (see “Unexpected Shakeup at Akcea” ). Cancer company Antengene Corp....
BioCentury | Dec 20, 2019
Product Development

Pharma spinouts: a snapshot of where and how pharmas spin out their assets

...pharma spinouts, five companies were spun out in China. In 2017, Celgene Corp. spun out Antengene Corp....
BioCentury | Nov 7, 2019
Product Development

AZ replants R&D roots in China, goes all-in on innovation

...Medical Technology licensed AZD3229, a c-Kit inhibitor; Antengene Corp....
...Lilly and Co. Novoheart Holdings Inc. Sun Pharmaceutical Industries Ltd. Antengene Corp. Abbisko...
BioCentury | Jan 4, 2019
Financial News

China's Antengene raises $120M series B round

...Corporate Venture Fund, Taikang and existing investors Qiming Venture Partners and TF Capital. Qiming led Antengene’s...
...liposarcoma and Phase II testing for diffuse large B cell lymphoma and glioblastoma in China. Antengene...
...Korea and other East and Southeast Asian territories, excluding Japan (see "Celgene, Antengene Deal" ). Antengene...
BioCentury | Jan 2, 2019
Financial News

China's Antengene raises $120M series B round

...Corporate Venture Fund, Taikang and existing investors Qiming Venture Partners and TF Capital. Qiming led Antengene’s...
...liposarcoma and Phase II testing for diffuse large B cell lymphoma and glioblastoma in China. Antengene...
...Southeast Asian territories, excluding Japan (see "China's Antengene in Deal for Celgene Cancer Candidate" ). Antengene...
Items per page:
1 - 10 of 19